A possible new approach to combating Staph infections.
Strauss
E
E
D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000276:immunology* / Q000378:metabolism / Q000627:therapeutic use*; D001427:Bacterial Toxins / Q000096:biosynthesis; D001428:Bacterial Vaccines; D015964:Gene Expression Regulation, Bacterial; D006801:Humans; D051379:Mice; D009842:Oligopeptides / Q000378:metabolism / Q000627:therapeutic use*; D016372:RNA, Antisense / Q000037:antagonists & inhibitors / Q000378:metabolism; D012329:RNA, Bacterial / Q000037:antagonists & inhibitors / Q000378:metabolism; D015398:Signal Transduction; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control*; D013211:Staphylococcus aureus / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity*; D014611:Vaccination; D014774:Virulence
D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D001428:Bacterial Vaccines; D009842:Oligopeptides; D016372:RNA, Antisense; D012329:RNA, Bacterial; C111711:RNAIII inhibiting peptide; C096035:RNAIII, Staphylococcus aureus